Difference between revisions of "WSI24-200-Case-4"

@@ Line 1: / Line 1: @@
 {{ServiceRequestCase
-|identifier=WSI24-200-Case-4
+|requisition=Liver Neoplasm Outs - 9/16/2024
+|subject=MGH
 |intent=order
+|category=409073007
+|occurrenceDateTime=2024-09-20 12:00:00-04:00
+|basedOn=WSI24-200
+|priority=Routine
 |code=apdidactic
-|category=409073007
+|orderDetail=case
-|subject=MGH
+|authoredOn=2024-09-16 20:07:52.122101+00:00
 |requester=Az375
+|locationCode=learn
+|sequence=4
 |performer=Az375
-|orderDetail=case
+|reasonCode=50yo woman with a history of breast cancer and thyroid cancer, presences with a 1 cm liver lesion suspicious for metastasis
-|locationCode=learn
+|supportingInfo=Hepatocellular adenoma, inflammatory subtype
+|identifier=WSI24-200-Case-4
 |access=public
 |status=active
 |origin=CPOE
-|priority=Routine
-|basedOn=WSI24-200
-|requisition=Liver Neoplasm Outs - 9/16/2024
-|reasonCode=50yo woman with a history of breast cancer and thyroid cancer, presences with a 1 cm liver lesion suspicious for metastasis
-|occurrenceDateTime=2024-09-20 12:00:00-04:00
-|authoredOn=2024-09-16 20:07:52.122101+00:00
-|sequence=4
-|supportingInfo=Hepatocellular adenoma, inflammatory subtype
-}}
-{{status
-|status=active
-|requester=Az375
-|authoredOn=2024-09-16 20:07:52.122101+00:00
 }}
 {{Media
-|identifier=772a4a09-c213-4a4b-9129-c6242cfa9460
 |operator=Az375
+|frames=1
 |status=completed
-|frames=1
+|reasonCode=Beta-catenin
 |view=show
-|reasonCode=B-Catenin (T-C) B5
+|identifier=772a4a09-c213-4a4b-9129-c6242cfa9460
-|basedOn=WSI24-200-Case-4
 }}
 {{Media
-|identifier=1055a5c9-b133-497e-97fe-dc6ef7e8ccc8
 |operator=Az375
+|frames=2
 |status=completed
-|frames=2
+|reasonCode=Glutamine synthetase (GS)
 |view=show
-|reasonCode=GS B3
+|identifier=1055a5c9-b133-497e-97fe-dc6ef7e8ccc8
-|basedOn=WSI24-200-Case-4
 }}
 {{Media
-|identifier=e393dfb0-df3a-4b34-b393-60720144c931
 |operator=Az375
+|frames=3
 |status=completed
-|frames=3
+|reasonCode=Fatty acid binding protein (FABP1)
 |view=show
-|reasonCode=FABP1 (2MT) B3
+|identifier=e393dfb0-df3a-4b34-b393-60720144c931
-|basedOn=WSI24-200-Case-4
 }}
 {{Media
-|identifier=69bd61e1-c10a-4239-9499-6aba2c54ebd8
 |operator=Az375
+|frames=4
 |status=completed
-|frames=4
+|reasonCode=Serum amyloid A (SAA1)
 |view=show
-|reasonCode=SAA B9 (2MT)
+|identifier=69bd61e1-c10a-4239-9499-6aba2c54ebd8
-|basedOn=WSI24-200-Case-4
 }}
 {{Media
-|identifier=a1271068-281a-4c2d-96ff-bcdd66a241b8
 |operator=Az375
+|frames=5
 |status=completed
-|frames=5
 |view=show
-|reasonCode=SAA B9 (2MT)
+|identifier=a1271068-281a-4c2d-96ff-bcdd66a241b8
-|basedOn=WSI24-200-Case-4
 }}
 {{Media
-|identifier=b5bf5c0e-3682-47f3-94dc-3341061eeb88
 |operator=Az375
+|frames=6
 |status=completed
-|frames=6
+|reasonCode=H&E
 |view=show
-|reasonCode=Level 2 (H&E)
+|identifier=b5bf5c0e-3682-47f3-94dc-3341061eeb88
-|basedOn=WSI24-200-Case-4
 }}
 {{Media
-|identifier=5966b100-50ed-42cd-8c88-f2628f9efa79
 |operator=Az375
+|frames=7
 |status=completed
-|frames=7
+|reasonCode=H&E
 |view=show
-|reasonCode=Level 2 (H&E)
+|identifier=5966b100-50ed-42cd-8c88-f2628f9efa79
-|basedOn=WSI24-200-Case-4
+}}
+{{status
+|status=active
+|requester=Az375
+|authoredOn=2024-09-16 20:07:52.122101+00:00
 }}

Difference between revisions of "WSI24-200-Case-4"

Revision as of 15:15, September 16, 2024